AI-generated analysis. Always verify with the original filing.
CV Sciences, Inc. filed an 8-K on March 10, 2026, disclosing a material definitive agreement entered into on February 12, 2025, which also created a direct financial obligation and involved an unregistered securities offering. Exhibits 10.1 and 10.2 reference the agreement dated March 4, 2026, with confidential portions omitted.
Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement As previously disclosed, on February 12, 2025, CV Sciences, Inc., a Delaware corporation (the “Company”) entered into
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information set forth under Item 1.01 of t
. The securities described therein have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and were issued in reliance upo
Financial Statements and Exhibits (d) Exhibits 10.1 Agreement dated March 4, 2026 (confidential portions of the exhibit have been omitted where indicated) 10.2